The NHLBI Small Market Awards support Phase II SBIR or STTR awardees developing products for rare diseases or young pediatric populations in the heart, lung, blood, and sleep disorder areas. This grant aims to validate products for continued development with private funding. Applicants need a Commercialization Plan with secured or anticipated third-party funding equal to or greater than one-third of the NHLBI funds. Projects must seek Federal regulatory approval, involving preclinical and/or clinical stages without mandatory clinical trials. Closing date for application is July 9, 2020.
Opportunity ID: 305218
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-HL-19-018 |
| Funding Opportunity Title: | NHLBI SBIR Phase IIB Small Market Awards to Accelerate the Commercialization of Technologies for Heart, Lung, Blood, and Sleep Disorders and Diseases (R44 Clinical Trial Optional) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | 2 |
| Assistance Listings: | 93.233 — National Center on Sleep Disorders Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 2 |
| Posted Date: | May 16, 2018 |
| Last Updated Date: | May 16, 2018 |
| Original Closing Date for Applications: | Jul 09, 2020 |
| Current Closing Date for Applications: | Jul 09, 2020 |
| Archive Date: | Aug 14, 2020 |
| Estimated Total Program Funding: | $700,000 |
| Award Ceiling: | $1,000,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Small businesses |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The purpose of the NHLBI SBIR Phase IIB Small Market Award is to provide support to Phase II SBIR or STTR awardees that are developing NHLBI mission-related products that address a rare disease or young pediatric populations. The goal of this FOA is for these products to be further validated so that development can continue with private funding after NHLBI support ends. Applicants must submit a Commercialization Plan that includes details on any independent third-party funding that has already been secured or is anticipated during the project period. It is expected that the level of this independent third-party funding will be equal to or greater than one-third of the NHLBI funds being requested throughout the project period. Projects proposed in response to this FOA must require eventual Federal regulatory approval/clearance, and may address preclinical and/or clinical stages of technology development. Clinical trials may be proposed as appropriate, but are not required. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-HL-19-018.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
| Updated funding in accordance with NOT-TR-18-026 | May 16, 2018 | |
| May 16, 2018 |
DISPLAYING: Synopsis 2
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-HL-19-018 |
| Funding Opportunity Title: | NHLBI SBIR Phase IIB Small Market Awards to Accelerate the Commercialization of Technologies for Heart, Lung, Blood, and Sleep Disorders and Diseases (R44 Clinical Trial Optional) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | 2 |
| Assistance Listings: | 93.233 — National Center on Sleep Disorders Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 2 |
| Posted Date: | May 16, 2018 |
| Last Updated Date: | May 16, 2018 |
| Original Closing Date for Applications: | Jul 09, 2020 |
| Current Closing Date for Applications: | Jul 09, 2020 |
| Archive Date: | Aug 14, 2020 |
| Estimated Total Program Funding: | $700,000 |
| Award Ceiling: | $1,000,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Small businesses |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The purpose of the NHLBI SBIR Phase IIB Small Market Award is to provide support to Phase II SBIR or STTR awardees that are developing NHLBI mission-related products that address a rare disease or young pediatric populations. The goal of this FOA is for these products to be further validated so that development can continue with private funding after NHLBI support ends. Applicants must submit a Commercialization Plan that includes details on any independent third-party funding that has already been secured or is anticipated during the project period. It is expected that the level of this independent third-party funding will be equal to or greater than one-third of the NHLBI funds being requested throughout the project period. Projects proposed in response to this FOA must require eventual Federal regulatory approval/clearance, and may address preclinical and/or clinical stages of technology development. Clinical trials may be proposed as appropriate, but are not required. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-HL-19-018.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
DISPLAYING: Synopsis 1
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-HL-19-018 |
| Funding Opportunity Title: | NHLBI SBIR Phase IIB Small Market Awards to Accelerate the Commercialization of Technologies for Heart, Lung, Blood, and Sleep Disorders and Diseases (R44 Clinical Trial Optional) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | 2 |
| Assistance Listings: | 93.233 — National Center on Sleep Disorders Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | May 16, 2018 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | Jul 09, 2020 |
| Archive Date: | Aug 14, 2020 |
| Estimated Total Program Funding: | $2,000,000 |
| Award Ceiling: | $1,000,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Small businesses |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The purpose of the NHLBI SBIR Phase IIB Small Market Award is to provide support to Phase II SBIR or STTR awardees that are developing NHLBI mission-related products that address a rare disease or young pediatric populations. The goal of this FOA is for these products to be further validated so that development can continue with private funding after NHLBI support ends. Applicants must submit a Commercialization Plan that includes details on any independent third-party funding that has already been secured or is anticipated during the project period. It is expected that the level of this independent third-party funding will be equal to or greater than one-third of the NHLBI funds being requested throughout the project period. Projects proposed in response to this FOA must require eventual Federal regulatory approval/clearance, and may address preclinical and/or clinical stages of technology development. Clinical trials may be proposed as appropriate, but are not required. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-HL-19-018.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-E | Use for due dates on or before May 24, 2020 | PKG00242222 | Jun 27, 2018 | May 24, 2020 | View | |
| FORMS-F | Use for due dates on or after May 25, 2020 | PKG00260200 | Jun 27, 2018 | Jul 09, 2020 | View |
Package 1
Mandatory forms
305218 RR_SF424_2_0-2.0.pdf
305218 PHS398_CoverPageSupplement_4_0-4.0.pdf
305218 RR_OtherProjectInfo_1_4-1.4.pdf
305218 PerformanceSite_2_0-2.0.pdf
305218 RR_KeyPersonExpanded_2_0-2.0.pdf
305218 RR_Budget_1_4-1.4.pdf
305218 PHS398_ResearchPlan_4_0-4.0.pdf
305218 SBIR_STTR_Information_1_2-1.2.pdf
Optional forms
305218 RR_SubawardBudget30_1_4-1.4.pdf
305218 PHS_AssignmentRequestForm_2_0-2.0.pdf
Package 2
Mandatory forms
305218 RR_SF424_2_0-2.0.pdf
305218 PHS398_CoverPageSupplement_5_0-5.0.pdf
305218 RR_OtherProjectInfo_1_4-1.4.pdf
305218 PerformanceSite_2_0-2.0.pdf
305218 RR_KeyPersonExpanded_2_0-2.0.pdf
305218 RR_Budget_1_4-1.4.pdf
305218 PHS398_ResearchPlan_4_0-4.0.pdf
305218 SBIR_STTR_Information_1_3-1.3.pdf
305218 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
305218 RR_SubawardBudget30_1_4-1.4.pdf
305218 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
